Literature DB >> 6159408

Antigen and receptor-driven regulatory mechanisms. VI. Demonstration of cross-reactive idiotypic determinants on azobenzenearsonate-specific antigen-binding suppressor T cells producing soluble suppressor factor(s).

M H Dietz, M S Sy, M I Greene, A Nisonoff, B Benacerraf, R N Germain.   

Abstract

The first detectable suppressor T cell (Ts) arising after i.v. administration of azobenzenearsonate- (ABA) conjugated syngeneic spleen cells to A/J mice has been studied for its receptor specificity and ability to produce soluble suppressor factor(s). This cell, termed Ts1, has a specific receptor for the eliciting antigen ABA, as demonstrated by selective binding to ABA protein- but not TNP protein-coated plastic dishes. The activity of ABA-Ts1 can be abrogated by treatment with anti-idiotypic antibodies made against anti-ABA antibodies of A/J mice (anti-CRI), indicating that these ABA-binding cells possess a surface receptor structure sharing idiotypic determinants with antibodies of the same specificity. Finally, soluble extracts from, antigen-adherent ABA-Ts1, but not nonadherent cells from the same spleen cell population, possess suppressive activity when assayed directly for afferent suppression or tested for their ability to trigger a second population of Ts (Ts2) in naive recipients. These findings demonstrate a close concordance between a T cell surface receptor, soluble T suppressor factors, and B cell derived antibody, all capable of direct recognition of the eliciting ABA antigen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Characterization of efferent T suppressor cells induced by Paracoccidioides brasiliensis-specific afferent T suppressor cells.

Authors:  B E Jimenez-Finkel; J W Murphy
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Immune reactions in the eye.

Authors:  C S Foster; R Wetzig
Journal:  Surv Immunol Res       Date:  1982

3.  Independent regulation of serologically distinct idiotypes in F1 hybrid mice.

Authors:  T F Kresina; M J Nelles; A Nisonoff; A R Brown
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cells.

Authors:  M H Dietz; M S Sy; B Benacerraf; A Nisonoff; M I Greene; R N Germain
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

5.  Regulation of timothy grass pollen IgE antibody formation. I. In-vitro induction of suppressor T cells by soluble T suppressor factors.

Authors:  A Malley; D W Dresser
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

6.  Abnormalities of third-order suppressor T cells in old (New Zealand black x New Zealand white) F1 mice.

Authors:  K Okuda; S Nagaoka; K Katoh; K Matsunaga; Y Ishigatubo; M Minami; K Tani
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

7.  Suppressor factor from a T cell hybrid inhibits delayed-type hypersensitivity responses to azobenzenearsonate.

Authors:  R B Whitaker; J T Nepom; M S Sy; M Takaoki; C F Gramm; I Fox; R N Germain; M J Nelles; M I Greene; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

8.  Antigen- and receptor-driven regulatory mechanisms. VIII. Suppression of idiotype-negative, p-azobenzenearsonate-specific T cells results from the interaction of an anti-idiotypic second-order T suppressor cell with a cross-reactive-idiotype-positive, p-azobenzenearsonate-primed T cell target.

Authors:  M S Sy; A Nisonoff; R N Germain; B Benacerraf; M I Greene
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

9.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VIII. Suppressor cell pathways in cutaneous sensitivity responses.

Authors:  M E Sunday; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.